XETRA - Delayed Quote EUR

Moderna, Inc. (0QF.DE)

41.53

-0.47

(-1.11%)

At close: January 10 at 5:35:31 PM GMT+1

The Score: Meta Platforms, Moderna, Edison International and More Stocks That Defined the Week

Meta Platforms is ending fact-checking and speech restrictions across Facebook and Instagram, as Chief Executive Mark Zuckerberg embraces a second Trump presidency. Starting in the U.S., Meta will be replacing fact-checkers with a so-called Community Notes system. Zuckerberg built up Facebook’s content-policing efforts in the wake of Trump’s first presidential election.

The Wall Street Journal yesterday

NWS

NWSA

NWSAL
Jim Cramer on Moderna, Inc. (MRNA): ‘The Numbers Here Are Staggering, Staggeringly Bad’

We recently compiled a list of the 10 S&P 500 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other S&P 500 stocks. Jim Cramer, host of Mad Money, recently discussed the current state of the market and also discussed both the […]

Insider Monkey yesterday

MRNA

^GSPC
AI, vaccine distrust, & the future of healthcare: Novartis CEO

Can science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian Sozzi talks at length with Novartis (NVS) CEO Vas Narasimhan. Narasimhan has led the drug giant since 2018, doing deals that have expanded the company’s pipeline in areas like heart disease and cancer. Still, Narasimhan is feeling pressure to bring the investments to the bottom line to jumpstart its stock price.  In the last year, Novartis shares have declined 6.69%. During that same timespan, the S&P 500 and Dow Jones Industrial Average have gained 22.8% and 12%, respectively. The iShares U.S. Healthcare ETF (IYH) is up slightly in the past year. The stock prices of Pfizer (PFE) and Moderna (MRNA) are down 8.5% and 61%, respectively in the past year. For full episodes of Opening Bid, listen on your favorite podcast platform or watch on our website.

Yahoo Finance Video yesterday

PFE

NVS

NVSEF
Moderna Gambling on China as Other U.S. Companies Pull Back

The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of intellectual-property theft in China.

The Wall Street Journal 2 days ago

MRNA
These Stocks Moved the Most Today: Nvidia, AMD, Palantir, IonQ, Moderna, Vir, Edison International, Constellation Energy, and More

Nvidia shares are flat after falling sharply in the previous session, Palantir stock extends declines, and quantum-computing stocks sink following comments from Nvidia’s CEO.

Barrons.com 3 days ago

NVDA

MRNA

RGTIW
Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week.

Yahoo Finance 3 days ago

PFE

CVAC

MRNA
Why Moderna Inc. (MRNA) Is Skyrocketing

We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other firms post strong gains amid Wall Street bloodbath. Wall Street’s main indices closed sharply in the red on Tuesday, as investors shifted […]

Insider Monkey 3 days ago

MRNA
"Motley Fool Money" 2025 Stock Market Preview

New year, new market? Motley Fool analysts preview what's in store for investors in 2025, the companies they're excited to watch and the businesses they're worried about.

Motley Fool 3 days ago

MRNA

^GSPC

AMD
There’s a ‘Shadow’ Over Biotech Stocks. Why It Isn‘t All Bad News.

Pharmaceutical and biotech stocks may find it tough to outperform the market in the months ahead. Nonspecialist investors have shifted their focus to other sectors, such as tech, following the outcome of the election and uncertainty about what it will mean for the industry, they said. “We believe President-elect Trump will be capable of enacting significant change, and the unpredictability is expected to cast a shadow over the space,” analysts led by Trung Huynh said in their 2025 outlook on the sector.

Barrons.com 3 days ago

PFE

MRNA
Moderna Stock Skyrockets 21% as H5N1 Flu Death Sparks Vaccine Hopes and Investor Frenzy

Moderna rallies as H5N1 avian flu spreads, boosting interest in its mRNA vaccine and federal backing

GuruFocus.com 3 days ago

MRNA
5 Things to Know Before the Stock Market Opens

News of the day for Jan. 8, 2025

Investopedia 3 days ago

MRNA
Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death

The first bird-flu fatality in the United States sparks investor interest in several vaccine makers that are developing experimental H5N1 vaccines.

Zacks 3 days ago

NVAX

MRNA

CVAC
Moderna (MRNA) Stock Jumps 11.7%: Will It Continue to Soar?

Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks 3 days ago

MRNA

RCUS
Prediction: These Could Be the Best-Performing Value Stocks Through 2030

Value stocks have lagged well behind growth stocks in recent years. D.R. Horton (NYSE: DHI) is the largest homebuilder in the U.S. based on volume -- a status it's held since 2002. The company operates in 36 states.

Motley Fool 3 days ago

PFE

MRNA

DHI
Moderna Price Levels to Watch After Stock's 12% Surge on Tuesday

Moderna shares soared as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu vaccine could boost sales after the first death linked to the disease was reported in the U.S. Monitor these important chart levels.

Investopedia 3 days ago

MRNA
S&P 500 Gains and Losses Today: Moderna Soars on Bird Flu Vaccine Potential

The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest rate outlook.

Investopedia 4 days ago

^GSPC

MRNA
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike

Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests.

Investor's Business Daily 4 days ago

MRNA

BNTX

NVAX
Moderna: 11.6% Increase After Bearish Options Sentiment Detected Days Before

Moderna Soars Despite Bearish Options Bets

GuruFocus.com 4 days ago

MRNA
Moderna Stock Soars After First US Bird-Flu Death

Moderna led S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for H5N1.

Investopedia 4 days ago

MRNA

^GSPC
Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death

The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through North America.

Barrons.com 4 days ago

MRNA

PFE

CVAC

Performance Overview

Return	0QF.DE	S&P 500
YTD	+7.86%	-1.35%
1-Year	-59.38%	+22.51%
3-Year	-78.32%	+24.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Moderna, Inc. (0QF.DE)

The Score: Meta Platforms, Moderna, Edison International and More Stocks That Defined the Week

Jim Cramer on Moderna, Inc. (MRNA): ‘The Numbers Here Are Staggering, Staggeringly Bad’

AI, vaccine distrust, & the future of healthcare: Novartis CEO

Moderna Gambling on China as Other U.S. Companies Pull Back

These Stocks Moved the Most Today: Nvidia, AMD, Palantir, IonQ, Moderna, Vir, Edison International, Constellation Energy, and More

Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus

Why Moderna Inc. (MRNA) Is Skyrocketing

"Motley Fool Money" 2025 Stock Market Preview

There’s a ‘Shadow’ Over Biotech Stocks. Why It Isn‘t All Bad News.

Moderna Stock Skyrockets 21% as H5N1 Flu Death Sparks Vaccine Hopes and Investor Frenzy

5 Things to Know Before the Stock Market Opens

Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death

Moderna (MRNA) Stock Jumps 11.7%: Will It Continue to Soar?

Prediction: These Could Be the Best-Performing Value Stocks Through 2030

Moderna Price Levels to Watch After Stock's 12% Surge on Tuesday

S&P 500 Gains and Losses Today: Moderna Soars on Bird Flu Vaccine Potential

Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike

Moderna: 11.6% Increase After Bearish Options Sentiment Detected Days Before

Moderna Stock Soars After First US Bird-Flu Death

Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death

Performance Overview